Teladoc Health Inc. (TDOC) saw its stock soar 5.05% in Monday's after-hours trading, driven by the announcement of a new collaboration with Amazon to expand access to Teladoc's industry-leading chronic condition management programs.
The partnership enables eligible Amazon customers to seamlessly discover and enroll in Teladoc's cardiometabolic programs for diabetes, hypertension, pre-diabetes, and weight management directly through Amazon's Health Benefits Connector. This move aims to improve access to needed care and help people manage their health in an easier and more convenient way.
"This partnership helps deliver on our strategy to bring greater value to our customers in our individual solutions and across our integrated offerings," said Chuck Divita, Chief Executive Officer of Teladoc Health. "By enabling customers to discover and enroll in our programs on Amazon, this effort will improve access to needed care and help people manage their health in an easier and more convenient way."
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。